← Eichor
Study identifier: NCT07159334 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

"Lignocaine vs GTN Ointment for Postoperative Pain After Hemorrhoidectomy")

Condition: Hemorrhoid · Postoperative Pain  ·  Sponsor: King Edward Medical University

PhaseNA
Planned participants64
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

This study is being conducted at the Department of General Surgery, King Edward Medical University, Lahore, Pakistan. The purpose of the trial is to compare the effectiveness of topical Lignocaine ointment versus topical Glyceryl Trinitrate (GTN) ointment in reducing postoperative pain following hemorrhoidectomy. Patients undergoing hemorrhoidectomy will be randomly assigned to receive either Lignocaine ointment or GTN ointment applied locally after surgery. Pain relief will be assessed using a visual analog scale (VAS) at regular intervals during the postoperative period. The study aims to determine which ointment provides better pain control and improves patient comfort during recovery.

This description comes directly from the study's public registry record.

Talk to the study team

Hafiz Ahmad Rauf, Mbbs,Fcps  ·  +923006023465  ·  ahmadrauf498@gmail.com

KEMU/ Mayo Hospital lahore  ·  +924299214819  ·  info@kemu.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

King Edward Medical uUniveristy Mayo HospitalLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07159334